Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Interest Paid (2014 - 2019)

Updated

Immunic's Interest Paid was -$32,000 in Q3 2019.

Analysis

Immunic (IMUX) Interest Paid (2014 - 2019) Analysis & Trends

For FY2012, Interest Paid at Immunic came in at $32,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Immunic 341.81 Mn -50.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -2,000.00
Sep 30, 2019 -32,000.00
Mar 31, 2014 518,000.00
API Access

Immunic Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=IMUX&period=max&api_key=YOUR_API_KEY